PTPRC and glioma: Additionally, the use of PD-L1 siRNA, to down modulate PD-L1 on glioma cell lines, reduced CD45+ cell death in D54- and U251- but not SF767- co-cultures (Figure 5C), thus supporting the causative role of PD-L1 in glioma killing of immune cells.